William Blair Investment Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,035,475
Closed -$34.1M 427
2025
Q3
$34.1M Sell
4,035,475
-289,408
-7% -$2.81M 0.09% 188
2025
Q2
$48.7M Sell
4,324,883
-79,054
-2% -$726K 0.13% 141
2025
Q1
$41.7M Sell
4,403,937
-377,194
-8% -$3.81M 0.12% 161
2024
Q4
$53.8M Sell
4,781,131
-158,175
-3% -$2.78M 0.13% 146
2024
Q3
$140M Sell
4,939,306
-86,737
-2% -$2.24M 0.34% 100
2024
Q2
$96.1M Buy
5,026,043
+1,308,376
+35% +$33.4M 0.25% 102
2024
Q1
$122M Sell
3,717,667
-60,786
-2% -$1.94M 0.32% 93
2023
Q4
$125M Buy
3,778,453
+1,156,004
+44% +$32.7M 0.36% 92
2023
Q3
$71.4M Sell
2,622,449
-48,511
-2% -$1.35M 0.24% 119
2023
Q2
$80.9M Buy
+2,670,960
New +$86.4M 0.26% 112

Other funds holding EVH

William Blair Investment Management's EVH Position: Q4 2025 in Review

William Blair Investment Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 4,035,475 shares — an estimated $34.1M sold.

William Blair Investment Management first reported a position in EVH in Q2 2023 and held it in 10 quarters. The position peaked at $140M in Q3 2024. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • William Blair Investment Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • William Blair Investment Management sold 4,035,475 Evolent Health shares in Q4 2025, an estimated $34.1M.
  • William Blair Investment Management first reported a position in Evolent Health in Q2 2023 and held it in 10 quarters.
  • William Blair Investment Management's Evolent Health position peaked at $140M in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on William Blair Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.